Emerging Role of PET in the Diagnosis and Staging of Lung Cancer
Positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose (FDG) has recently emerged as a practical and useful imaging modality in patients with lung cancer. Malignant tumours demonstrate increased uptake of FDG, a positron-emitting radiopharmaceutical. This increased FDG uptake in tumours c...
Saved in:
Main Authors: | Geoffery Coates, Stephen J Skehan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1999-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/1999/717104 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of New Functional MRI Techniques in the Diagnosis, Staging, and Followup of Gynecological Cancer: Comparison with PET-CT
by: Elena Alvarez Moreno, et al.
Published: (2012-01-01) -
Incidental Phaeochromocytoma on Staging PET-CT in a Patient with a Sigmoid Tumour and Situs Inversalis Totalis
by: M. R. Boland, et al.
Published: (2014-01-01) -
PET/SPECT Molecular Probes for the Diagnosis and Staging of Nonalcoholic Fatty Liver Disease
by: Tuo Shao PhD, et al.
Published: (2019-09-01) -
[18F]FDG PET/CT versus [18F]FDG PET/MRI in staging of non-small cell lung cancer: a head-to-head comparative meta-analysis
by: Dandan Yu, et al.
Published: (2025-01-01) -
Mediastinal Staging for Lung Cancer
by: Jacob Gelberg, et al.
Published: (2014-01-01)